Objective: This study evaluates the benefits of and indications for the orb
ito-cranial approach (OCA) in pediatric patients. Methods and results: The
authors report their recent experience of using the OCA in 9 pediatric pati
ents, 6 boys and 3 girls. The patients' ages ranged from 3 to 17 years (mea
n 9.6 +/-5.16 years). Follow-up periods varied between 6 and 21 months (mea
n 12.6 +/-5.9 months). Five patients were operated on for craniopharyngioma
s, 2 for chiasmatic-hypothalamic astrocytomas, 1 for a recurrent hypothalam
ic gangliocytoma, and 1 for a hypothalamic hamartoma. In 7 cases a neuronav
igation system (BrainLab) was utilized. The lesions were removed totally in
5 patients, near-totally in 1, subtotally in 2, and partially in 1 patient
. An average increase of 30% in the area of vertical exposure significantly
decreased the need for brain retraction. There was no mortality in this se
ries. The only complications connected with the surgical approach were tran
sient subgaleal cerebro-spinal fluid collections in 7 of 9 children and a s
ubgaleal-peritoneal shunt placement in another patient. Conclusions: Our ex
perience with this series of patients suggests that the OCA is as safe and
beneficial in pediatric patients as it is in adults. It facilitates tumor r
emoval by providing, shorter access to and better exposure of the suprasell
ar area, thereby minimizing brain retraction.